Klaus DUGI,Andreas CLEMENS,Thorsten LEHR,Herbert NOACK
申请号：
US13923762
公开号：
US20130345262A1
申请日:
2013.06.21
申请国别(地区):
US
年份:
2013
代理人:
摘要：
A method for administering Dabigatran, optionally in the form of a pharmaceutically acceptable salt thereof, to a patient in need of an anticoagulant and/or antithrombotic medicament wherein the daily dose is determined by the dosage regimen including one measurement of dabigatran plasma level.
